Clinical trial
Effect of Metformin Versus Repaglinide Treatment on Glycemic Control and Non-Glycaemic Cardiovascular Risk Factors in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet
NCT00118950 is registered in ClinicalTrials.gov with Steno Diabetes Center Copenhagen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Metformin Versus Repaglinide Treatment on Glycemic Control and Non-Glycaemic Cardiovascular Risk Factors in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet
- Lead sponsor
- Steno Diabetes Center Copenhagen
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2001
- Completion date
- March 31, 2003
- Enrollment
- 100
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.